Healthy Volunteers Clinical Trial
Official title:
Thyroid Hormone-Induced Lipolysis: An In Vivo Microdialysis Study
This study will use a technique called microperfusion to examine how thyroid hormones are
involved in fat metabolism. The thyroid gland produces two kinds of hormones: T3 and T4. Some
of the T4 is changed to T3 in various organs after leaving the thyroid. The T3 stimulates the
body to burn fat. People have different rates at which they can change T4 to T3, and this may
lead to differences in body fat among different people.
Microperfusion is based on the exchange of substances across tiny holes of a small plastic
tube called a "probe," which is inserted after numbing the skin over a fat pad. Through these
openings, the fat pad is continuously rinsed with small amounts of fluid, and an exchange of
substances occurs. The fluid drips from the other opening of the probe and is collected in a
vial. Small amounts of study drugs are infused and the amount of substances released by the
fat pad in response to them are measured.
Healthy normal volunteers 18 years of age and older may be eligible for this study.
Candidates are screened with a medical history, physical examination and blood tests.
Participants undergo microperfusion. A needle is placed in an arm vein for collecting blood
samples before and at the end of the experiment for measuring thyroid hormones and other
substances in the blood. The skin over the fat pad next to the umbilicus (navel) is numbed
and two microperfusion probes are inserted. A salt water solution is infused into the fat pad
for one hour and the substances in the fluid are measured as the fluid leaves the fat pad.
After 1 hour isoproterenol, a drug that aids in energy production by fat, is added to help
determine the level of fat metabolism. After an additional hour small amounts of thyroid
hormone are added to the fluid and samples are collected as they leave the body. Two
catheters are inserted during each experiment. Small volumes of sterile fluid are circulated
continuously in the tubing and samples are collected at regular intervals.
This study will examine how two thyroid preparations, levothyroxine (T4) and liothyronine
(T3), affect subcutaneous adipose tissue in normal subjects. Thyroid hormone plays an
important role in the maintenance of energy metabolism. Specifically, hyperthyroidism is
associated with weight loss via an increase in metabolic rate and lipolysis. While this
phenomenon has been studied in vitro quite extensively, very little information is available
on the local action of thyroid hormone on adipose tissue in vivo and, in particular, at the
present no information is available on the role of peripheral conversion of thyroid hormone
in subcutaneous adipose tissue. We thus propose to study the local action of thyroid hormones
on adipose tissue using microdialysis, a minimally invasive technique that allows the serial
determination of components of the extracellular fluid. The measurement of glycerol after
correction for changes in blood flow will be used to evaluate the effects of the thyroid
hormones on local lipolysis.
Healthy volunteers 18 years of age and older may be eligible for this study. Candidates are
screened with a medical history, physical examination, and blood tests. Subjects with
hyperlipidemia, impaired glucose tolerance or diabetes and thyroid disease are not eligible
for the participation in this study. Qualifying study participants undergo subcutaneous fat
tissue microdialysis to assess the effects of T3 and T4 on the activity of fat tissue. The
medications isoproterenol and T3 or T4 are injected in fat tissue under the skin of the
abdomen, and fluid samples are collected from the area over a 6-12 hour period using the same
small needle. Glycerol is then measured to study how the thyroid hormones affect fat
metabolism. During this procedure a 10% glucose solution is infused through the catheter in
the arm to limit lipolysis due to fasting. Four different sets of experiments are performed
with different thyroid hormone doses and/or durations.
These experiments will provide new information on the role of thyroid hormone in the
regulation of adipose tissue metabolism and will help in identifying new treatments for the
management of obesity.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |